Ken Templeton

Ken Templeton

Cortexyme (CRTX) could solve Alzheimer’s Disease

Cortexyme (CRTX) could solve Alzheimer's Disease

Cortexyme (CRTX) presents a causative mechanism for Alzheimer’s Disease (bacterial infection of the brain) that explains amyloid beta 1-42 accumulation, pTau production, and APOE4 genetic risk factors — all hallmarks of disease. CRTX is testing a patent-protected, orally-administered, first-in-class small molecule in a clinical trial to evaluate improvements…